Stock & Company Details
Beam Therapeutics Inc $BEAM
Price:
46,691,331
103M
$3.5B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-20.25
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
BEAM technical indicators
Latest Beam Therapeutics Inc (BEAM) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
55.01 5.9%
MACD:
1.18 6.8%
SMA 50:
$30.89 0.1%
SMA 200:
$27.56 0.2%
EMA 20:
$32.65 0.3%
Bollinger Bands:
36.48 / 27.80
Stochastic:
67.97 7.4%
ADX 14:
23.77 1.9%
ATR 14:
2.40 1.9%
CCI 20:
56.28 31.1%
OBV:
-6.43M 50.7%
ROC 12:
15.33% 8.2%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Finance Bot
Ask your questions
Start by typing a question below.
